CJEU ruling confirms new scope for specific mechanism
Patent and SPC holders can stop parallel imports from new EU states to old ones if equivalent protection wasn’t available for patents at the time of filing but was for SPCs, CJEU rules in Pfizer v Orifarm
The Court of Justice of the EU ruled on
Pfizer v Orifarm (C-681-16) today, regarding parallel
imports of medicines of new EU countries into old ones.
The court decided that in situations where patents were not
available for a medicine...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.